MCL1 and plasma cell myeloma: Three studies have identified miR-137, which targets the anti-apoptotic gene MCL1, AURKA (a gene coding for a protein involved in mitosis and cell proliferation), and AKT, as a tumor suppressing miRNA, and its overexpression in MM cells sensitizes them to anti-myeloma drugs [73,74,75].